A substantial percentage of patients with primary headache disorders are unresponsive to standard pharmacologic therapies, with pain-free response rates of 45% at 15 minutes and 30% at 2 hours, following the use of rescue medications.1 Such findings, along with the range of side effects associated with these agents, highlight the need for novel treatment options…
The use of ultrasound-guided transversus abdominis plane block in combination with general anesthesia during robotic partial nephrectomy may improve postoperative morphine consumption, the intensity of acute somatic pain, and the incidence of chronic pain.
Computed tomography-guided pulsed radiofrequency therapy may offer pain relief, improve quality of life, and reduce medication use in patients with trigeminal postherpetic neuralgia.
Evidence suggests that radiofrequency ablation of the sacral lateral branches may provide relief for pain that originates from the posterior sacroiliac joint complex.
A home-based anodal transcranial direct current stimulation of the dorsoprefrontal cortex of individuals with fibromyalgia may provide significant pain relief when used for an extended period.
Ultrasound-guided pulsed radiofrequency neuromodulation of the suprascapular nerve combined with injection of short-acting corticosteroids may safely and effectively relieve chronic shoulder pain.
Patients undergoing preoperative peripheral nerve block placement have a similar change in anxiolytic scores when they receive music medicine versus midazolam.
A new needle tip-tracking technology was found to reduce procedure time and the number of hand movements for clinicians performing ultrasound-guided out-of-plane peripheral nerve block procedures.
